Search hospitals > New York > New York
Columbia University
Claim this profileNew York, New York 10032
Global Leader in Alzheimer's Disease
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Stroke
Conducts research for Amyotrophic Lateral Sclerosis
629 reported clinical trials
85 medical researchers
Summary
Columbia University is a medical facility located in New York, New York. This center is recognized for care of Alzheimer's Disease, Cancer, Breast Cancer, Stroke, Amyotrophic Lateral Sclerosis and other specialties. Columbia University is involved with conducting 629 clinical trials across 951 conditions. There are 85 research doctors associated with this hospital, such as Richard Carvajal, MD, Ran Reshef, MD, Mark N. Stein, and Gary Schwartz, MD.Area of expertise
1Alzheimer's Disease
Global LeaderAPOE4 positive
2Cancer
Global LeaderStage IV
Stage III
FGFR3 positive
Top PIs
Richard Carvajal, MDColumbia University Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical Protoco3 years of reported clinical research
Studies Solid Tumors
Studies Melanoma
20 reported clinical trials
60 drugs studied
Ran Reshef, MDColumbia University Irving Medical Center4 years of reported clinical research
Studies Cancer
Studies Non-Hodgkin's Lymphoma
19 reported clinical trials
30 drugs studied
Mark N. SteinColumbia University Irving Medical Center2 years of reported clinical research
Expert in Prostate Cancer
Studies Cancer
18 reported clinical trials
33 drugs studied
Gary Schwartz, MDNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center2 years of reported clinical research
Studies Cancer
Studies Solid Tumors
14 reported clinical trials
37 drugs studied
Clinical Trials running at Columbia University
Lymphoma
Amyotrophic Lateral Sclerosis
Colorectal Cancer
Pancreatic Cancer
Stroke
Lung Cancer
Suicide
Skin Lymphomas
Heart Failure
Brain Tumor
ctDNA-Guided Therapy
for Non-Hodgkin's Lymphoma
The purpose of this study is to 1) determine whether it is feasible to measure circulating tumor DNA (ctDNA) in real-time during standard treatment for newly diagnosed diffuse large B-cell lymphoma (DLBCL), and 2) evaluate the outcomes of participants with undetectable ctDNA in the middle of treatment who receive a shortened course of chemotherapy. There are no investigational drug agents to be administered in this study. The investigational assay, phased variant enrichment and detection sequencing (PhasED-seq) will be used to guide de-escalation of standard-of-care therapy for newly diagnosed DLBCL. The PhasED-seq assay has not yet been approved by the Food and Drug Administration (FDA).
Recruiting1 award N/A5 criteria
Combination Therapy
for Non-Hodgkin's Lymphoma
This phase 2 trial studies the side effects and best dose of tazemetostat and zanubrutinib in combination with tafasitamab and lenalidomide, and to see how well these combinations work in treating patients with large B-cell lymphoma that returned or did not respond to earlier treatment. Tazemetostat is in a class of medications called EZH2 inhibitors. It helps to stop the spread of cancer cells. Zanubrutinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells. tafasitamab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Lenalidomide is in a class of medications called immunomodulatory agents. It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells in the bone marrow. The addition of tazemetostat or zanubrutinib to tafasitamab and lenalidomide may be able to shrink the cancer or extend the time without cancer symptoms coming back.
Recruiting1 award Phase 2
Fenretinide
for T-Cell Lymphoma
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).
Recruiting1 award Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Columbia University?
Columbia University is a medical facility located in New York, New York. This center is recognized for care of Alzheimer's Disease, Cancer, Breast Cancer, Stroke, Amyotrophic Lateral Sclerosis and other specialties. Columbia University is involved with conducting 629 clinical trials across 951 conditions. There are 85 research doctors associated with this hospital, such as Richard Carvajal, MD, Ran Reshef, MD, Mark N. Stein, and Gary Schwartz, MD.
Where is Columbia University located?
The Columbia University Irving Medical Center is situated in the Washington Heights neighborhood of northern Manhattan, New York City, at West 168th Street and Broadway. It is easily accessible by public transportation, with the 1, A, or C subway lines stopping at the 168th Street station, along with several city bus routes. For those driving, the recommended approach is via the George Washington Bridge, exiting onto Riverside Drive, then proceeding to West 165th Street, and finally turning right onto Fort Washington Avenue to reach the medical center's parking facility.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Columbia University Hospital, reach out to the Patient Financial Hardship department at 212-305-8400 or email PathBilling@cumc.columbia.edu for billing, insurance, or patient responsibility inquiries. For insurance-related questions, contact the Patient Accounting Department at 518.828.8051, available Monday-Friday, 8 a.m. to 4 p.m.
What insurance does Columbia University accept?
NewYork-Presbyterian Hospital, affiliated with Columbia University, accepts a range of insurance plans such as Aetna, Cigna, United Healthcare, and WellCare. Columbia University employees have access to four comprehensive medical plan options through UnitedHealthcare, which include vision and prescription drug coverage. Columbia University students benefit from dental and vision discounts under the Student Health Insurance Plan, administered by Aetna.
What awards or recognition has Columbia University received?
Columbia University Medical Center is renowned for its PTSD Research and Treatment Program, aimed at improving understanding of PTSD, trauma resilience, and developing neuroscience-informed treatments. It is also celebrated for its leadership in medical education, groundbreaking research, and innovative patient care, with its sponsored research reaching hundreds of millions annually.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.